

Sabin Launches Global HPV Consortium
Sabin Vaccine Institute Leads Public and Private Sector Fight to Prevent HPV and End Cervical Cancer with Global HPV Consortium Launch in Kuala Lumpur

Global HPV Consortium Brochure
Mobilizing a transdisciplinary movement to prevent HPV and end cervical cancer.

HPV Factsheet
A snapshot of datapoints that underline the need for this Consortium.

Join the consortium
Be a part of the Consortium’s growing public and private sector collaboration and contribute in a variety of ways to the ongoing efforts to prevent HPV and cervical cancer.

Join Our Boost HPV Community
Connect and network with stakeholders, surface needs and challenges, share best practices, stay up-to-date on the latest news, and more.
An increased sense of urgency is needed as the world falls behind
Since introduction in 2006, HPV vaccines have proven safe and effective in protecting against infection and preventing cervical cancer. Yet, the burden of HPV diseases continues to rise with an estimated 600,000 new cases of cervical cancer and over 340,000 deaths each year.
To respond to these life-threatening trends, the Sabin Vaccine Institute, as consortium secretariat, along with a diverse, and expanding, set of partners will mobilize action across three pillars:
The Global HPV Consortium will be guided by global goals, including WHO’s Immunization Agenda 2030 and Cervical Cancer Elimination Initiative:
Who We Are
Consortium Partners
The Consortium partners will have an opportunity to contribute in a variety of ways:
Financial Partners
Providing financial resources to sustain the Consortium and support activities within the Action Plan.
Technical & Knowledge Partners
Contributing technical expertise and skills to the development of Consortium knowledge, training, and mentoring assets and activities.
Advocacy Partners
Giving voice to the goals of the Consortium and working in partnership to extend the impact of its work through their networks.
The Action Plan will include impactful and actionable steps to deliver on the promise of protection against the devastating effects of HPV through primary and secondary prevention.
The Plan will:
- Be informed by a sustained and dynamic community of global, national and sub-national stakeholders.
- Encompass issues from political commitment, financing, policy, through to community-level service delivery.
- Promote an on-the-ground alliance and convergence of multi-sectoral actors and institutions.
- Spotlight the voices of women, young people, and those most vulnerable to HPV and cervical cancer.
- Listen to and learn from communities about their needs and aspirations and activate impactful response.
- Spur and scale-up local innovation.
The Plan’s actionable framework will deliver on the promise of protection from HPV and cervical cancer by:
- Establishing feedback loops from global to sub-national levels for connection and accountability
- Dynamically distilling & disseminating best practices
- Applying a social & behavioral lens to HPV vaccine acceptance and demand challenges & solutions
- Fostering adaptive service delivery and leadership throughout the value chain
- Driving investment in innovation & impact
- Generating new knowledge and evidence

Be a part of the Consortium’s growing public and private sector collaboration